Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans...

Fri, Mar 6

Perspectives

Amazing study: GLP-1 drugs [Wegovy, Ozempic...] 'associated with reduced risks of developing various incident SUDs [addictions], suggesting a broad preventive effect across multiple substance types.' https://t.co/NzV981kNJU

6424

Objectives To investigate whether initiation of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with both reduced risks of incident alcohol, cannabis, cocaine, nicotine, opioid, and...

Discover